What are the key takeaways for Molina Healthcare Inc ($MOH)?

Revenue growth decelerated to -3.1% YoY in Q1 2026, marking a significant inflection point from the 8.3% growth seen in Q4 2025. Medical care costs continue to press on profitability, with Q1 2026 operating margins thinning to 0.8%, highlighting the volatility in managing government-sponsored plan costs. The company maintains a strong liquidity position with $5.314 billion in cash as of Q1 2026, providing flexibility for strategic M&A and capital management despite margin pressures.

Molina Healthcare Inc (MOH) AI Stock Analysis & Earnings

Please enable JavaScript to continue using this application.

Overview Charts AI Summary Financials Valuation

Based on March 31, 2026

Latest Report Overview for Molina Healthcare Inc ($MOH)

Molina Healthcare Inc $MOH reported Q1 2026 revenue of $10.796 billion, representing a 3.1% YoY decline. Net income for the quarter was $14 million, with an operating margin of 0.8% and a net margin of 0.1%. Operating cash flow was $1.082 billion for the period, supported by a cash balance of $5.314 billion. The company continues to face a challenging medical cost environment, with gross margins reported at 14.1% for Q1 2026. This performance reflects the ongoing pressures of managing high-acuity populations within its government-sponsored health plans, where medical care cost trends have frequently outpaced the rate increases granted by state and federal agencies.

Key Takeaways

1.Revenue growth decelerated to -3.1% YoY in Q1 2026, marking a significant inflection point from the 8.3% growth seen in Q4 2025.
2.Medical care costs continue to press on profitability, with Q1 2026 operating margins thinning to 0.8%, highlighting the volatility in managing government-sponsored plan costs.
3.The company maintains a strong liquidity position with $5.314 billion in cash as of Q1 2026, providing flexibility for strategic M&A and capital management despite margin pressures.
4.Strategic shift away from Medicare Advantage (MAPD) continues as the company focuses on its dual-eligible core competencies, exiting markets to improve long-term profitability.
5.Active management of the capital structure remains a priority, evidenced by the refinancing of debt and ongoing opportunistic share repurchases as authorized by the board.

What They Do

Molina Healthcare provides managed healthcare services under the Medicaid and Medicare programs and through state insurance marketplaces. Founded in 1980, the company focuses exclusively on government-sponsored healthcare for low-income families and individuals, including those dually eligible for Medicare and Medicaid. As of late 2025, the company served approximately 5.5 million members across 21 states. The business model is built on providing low-cost, effective health plans for state and federal government customers. Molina is unique in its dedicated focus on high-acuity, vulnerable populations, utilizing a centralized medical and administrative service platform. Scale indicators include annual premium revenues exceeding $43 billion, with a significant geographic footprint concentrated in states like California, New York, Texas, and Washington.

How They Make Money

Molina Healthcare's revenue is primarily generated through managed care contracts with state Medicaid agencies and the federal government for Medicare and Marketplace programs. The company receives fixed monthly per-member per-month (PMPM) premiums, which are recognized as revenue in the month members are entitled to services. Premium rates are set annually based on member demographics, health risk status, and expected medical cost trends. Revenue growth is driven by membership growth (organic and via acquisition) and successful state contract bids. Key metrics include the Medical Care Ratio (MCR), which is the primary indicator of operating performance, and the ability to win re-procurement bids for Medicaid and Medicare contracts. The company also monitors membership shifts between segments to manage acuity and risk adjustment revenues.

Competitive Position

Molina Healthcare competes against national managed care organizations, including Centene, UnitedHealth, CVS Health (Aetna), and Elevance Health, as well as regional players. The company's competitive advantage lies in its specialized focus on government-sponsored care, established provider networks, and administrative efficiency gained through centralized management and scaling AI administrative tools. Relative to peers, Molina's valuation is often shaped by the predictability of its government-contracted revenue streams versus the margin risks inherent in the Medicaid and Medicare businesses. While scale provides a moat, the competitive environment is intense, especially in states with high Medicaid participation. Vulnerabilities include pricing pressure from government payors, potential contract loss during re-bidding processes, and exposure to adverse acuity shifts in high-risk populations.

Business Strategy & Moat

Molina's strategy centers on being a 'pure-play' government-sponsored healthcare provider. The company focuses on organic growth through high win rates in state Medicaid RFPs and selective, accretive M&A to expand its geographic and segment footprint (e.g., ConnectiCare acquisition). Capital allocation is balanced between investing in technology (AI-driven cost management) and returning capital to shareholders through share repurchase programs. The moat is supported by regulatory and operational barriers to entry in Medicaid and dual-eligible Medicare programs, which require deep relationships with state agencies and specialized care management capabilities. However, the moat is challenged by the volatility of medical cost trends and the constant threat of state rate pressure. Management emphasizes operating leverage—scaling its centralized service platform across a growing membership base to drive long-term profitability.

Industry Outlook

The health care services sector is heavily influenced by government budget cycles and the regulatory environment. Key macro drivers include Medicaid redetermination processes, which continue to create membership volatility, and the shift toward integrated Medicare-Medicaid programs (D-SNP). Regulatory and legislative headwinds, such as the 'One Big Beautiful Bill Act' and CMS program integrity initiatives, remain significant factors creating uncertainty for enrollment and profitability. The sector faces ongoing pressures from high medical utilization trends and the need for health plans to adapt rapidly to evolving regulatory requirements in states with tightening fiscal budgets.

Growth Drivers

•Winning new Medicaid and Medicare state procurement contracts (e.g., recent wins in Idaho, Michigan, Massachusetts, Ohio, Wisconsin, Nevada, Illinois, Florida).
•Executing accretive M&A to consolidate fragmented government-sponsored health markets (e.g., ConnectiCare acquisition).
•Expansion of dual-eligible (D-SNP) membership as integrated programs replace older demonstration projects.
•Operating efficiencies through AI-driven medical and administrative cost management tools.
•Pricing and benefit design adjustments to restore profitability in the Marketplace segment.

Recent Developments

•Q1 2026: Reported revenue of $10.796 billion, showing a 3.1% YoY decline, highlighting continued pressure in the managed care segment.
•February 2026: Executed an amendment to the New Credit Agreement to temporarily reduce Interest Coverage Ratio thresholds through 2027.
•February 2026: Announced intent to exit the MAPD Medicare product line for 2027 to focus exclusively on dual-eligible members, anticipating a $93 million impairment charge.
•January 2026: Commenced multiple new state contracts in Idaho, Michigan, Massachusetts, Ohio, and Illinois.
•2025: Continued aggressive capital deployment with $1 billion total in share repurchases completed across Q1 and Q3 2025.
•May 2025: Withdrew legal action in Virginia regarding Medicaid procurement, leading to contract termination effective June 30, 2025.

Catalysts

•Outcome of upcoming Medicaid RFP bidding processes in key states for 2027-2028 contract cycles.
•Quarterly updates on the medical care ratio (MCR) to determine if cost management initiatives are stabilizing margins.
•Implementation and scaling of 2026 contract wins to drive revenue growth in the second half of the year.
•Potential legislative or CMS policy shifts impacting Medicare Advantage Star Ratings and reimbursement rates.
•Earnings results for Q2 2026, which will provide insight into the impact of the MAPD exit and ongoing cost-management strategies.

Acquisitions & Strategy

•Acquired ConnectiCare Holding Company, Inc. in February 2025 for $350M to expand presence in Connecticut's Marketplace and Medicare segments.

Share Repurchase / Buyback Program

•In April 2025, the board authorized a $1 billion share repurchase program extending through December 2026, which superseded the October 2024 program.
•The company repurchased $500 million in shares in Q1 2025 and $500 million in Q3 2025, utilizing the full $1 billion authorization from the prior programs.

RPO & Key Performance Indicators

•Membership base remains substantial at 5.5 million as of Q1 2026, with the company focusing on high-acuity member retention.
•The company's strategy is currently focused on shifting toward dual-eligible populations, expecting a 12% decrease in Medicare MAPD membership by end of 2026.

Strengths

•Consistent track record of winning and retaining Medicaid government contracts, with a ~90% re-procurement win rate.
•Robust capital foundation with $5.3 billion in cash and efficient management of statutory capital across regulated subsidiaries.
•Successful execution of long-term growth strategy through M&A and organic contract expansion in synergistic markets.
•Strong focus on administrative efficiency, consistently maintaining a competitive G&A ratio through centralized services.
•Deep clinical expertise in managing high-acuity, vulnerable populations, which is essential for success in government-sponsored programs.

AI Benefits & Opportunities

•Investments in AI tools are being used to automate administrative processes and streamline claims adjudication, aiming to improve operational efficiency and cost management.
•Deployment of AI is enhancing internal clinical functions, facilitating personalized member engagement and improved medical management effectiveness.

Risks & Concerns for Molina Healthcare Inc ($MOH)

You're one step away

Unlock the full risk analysis

See business risks, AI filing insights, and deeper research for this stock. Create a free account to continue — includes a 14-day Pro trial.

No card required • Free plan stays after trial

About this summary

AI-generated research for Molina Healthcare Inc (MOH, filings period ending March 31, 2026). AI summaries, reports, and scoring can be inaccurate or incorrect; accuracy and correctness are not guaranteed. Informational only; not investment advice or personalized guidance.Enumerated risk factors in this view may be abbreviated for anonymous or guest sessions. Full risk sections are available with full access.

Summary generated on Apr 25, 2026.

Peers of Molina Healthcare Inc (MOH)

Molina Healthcare Inc (MOH) AI Stock Analysis & Earnings

Based on March 31, 2026

Latest Report Overview for Molina Healthcare Inc ($MOH)

Key Takeaways

1.Revenue growth decelerated to -3.1% YoY in Q1 2026, marking a significant inflection point from the 8.3% growth seen in Q4 2025.
2.Medical care costs continue to press on profitability, with Q1 2026 operating margins thinning to 0.8%, highlighting the volatility in managing government-sponsored plan costs.
3.The company maintains a strong liquidity position with $5.314 billion in cash as of Q1 2026, providing flexibility for strategic M&A and capital management despite margin pressures.
4.Strategic shift away from Medicare Advantage (MAPD) continues as the company focuses on its dual-eligible core competencies, exiting markets to improve long-term profitability.
5.Active management of the capital structure remains a priority, evidenced by the refinancing of debt and ongoing opportunistic share repurchases as authorized by the board.

What They Do

How They Make Money

Competitive Position

Business Strategy & Moat

Industry Outlook

Growth Drivers

•Winning new Medicaid and Medicare state procurement contracts (e.g., recent wins in Idaho, Michigan, Massachusetts, Ohio, Wisconsin, Nevada, Illinois, Florida).
•Executing accretive M&A to consolidate fragmented government-sponsored health markets (e.g., ConnectiCare acquisition).
•Expansion of dual-eligible (D-SNP) membership as integrated programs replace older demonstration projects.
•Operating efficiencies through AI-driven medical and administrative cost management tools.
•Pricing and benefit design adjustments to restore profitability in the Marketplace segment.

Recent Developments

•Q1 2026: Reported revenue of $10.796 billion, showing a 3.1% YoY decline, highlighting continued pressure in the managed care segment.
•February 2026: Executed an amendment to the New Credit Agreement to temporarily reduce Interest Coverage Ratio thresholds through 2027.
•February 2026: Announced intent to exit the MAPD Medicare product line for 2027 to focus exclusively on dual-eligible members, anticipating a $93 million impairment charge.
•January 2026: Commenced multiple new state contracts in Idaho, Michigan, Massachusetts, Ohio, and Illinois.
•2025: Continued aggressive capital deployment with $1 billion total in share repurchases completed across Q1 and Q3 2025.
•May 2025: Withdrew legal action in Virginia regarding Medicaid procurement, leading to contract termination effective June 30, 2025.

Catalysts

•Outcome of upcoming Medicaid RFP bidding processes in key states for 2027-2028 contract cycles.
•Quarterly updates on the medical care ratio (MCR) to determine if cost management initiatives are stabilizing margins.
•Implementation and scaling of 2026 contract wins to drive revenue growth in the second half of the year.
•Potential legislative or CMS policy shifts impacting Medicare Advantage Star Ratings and reimbursement rates.
•Earnings results for Q2 2026, which will provide insight into the impact of the MAPD exit and ongoing cost-management strategies.

Acquisitions & Strategy

•Acquired ConnectiCare Holding Company, Inc. in February 2025 for $350M to expand presence in Connecticut's Marketplace and Medicare segments.

Share Repurchase / Buyback Program

•In April 2025, the board authorized a $1 billion share repurchase program extending through December 2026, which superseded the October 2024 program.
•The company repurchased $500 million in shares in Q1 2025 and $500 million in Q3 2025, utilizing the full $1 billion authorization from the prior programs.

RPO & Key Performance Indicators

•Membership base remains substantial at 5.5 million as of Q1 2026, with the company focusing on high-acuity member retention.
•The company's strategy is currently focused on shifting toward dual-eligible populations, expecting a 12% decrease in Medicare MAPD membership by end of 2026.

Strengths

•Consistent track record of winning and retaining Medicaid government contracts, with a ~90% re-procurement win rate.
•Robust capital foundation with $5.3 billion in cash and efficient management of statutory capital across regulated subsidiaries.
•Successful execution of long-term growth strategy through M&A and organic contract expansion in synergistic markets.
•Strong focus on administrative efficiency, consistently maintaining a competitive G&A ratio through centralized services.
•Deep clinical expertise in managing high-acuity, vulnerable populations, which is essential for success in government-sponsored programs.

AI Benefits & Opportunities

•Investments in AI tools are being used to automate administrative processes and streamline claims adjudication, aiming to improve operational efficiency and cost management.
•Deployment of AI is enhancing internal clinical functions, facilitating personalized member engagement and improved medical management effectiveness.

Risks & Concerns for Molina Healthcare Inc ($MOH)

You're one step away

Unlock the full risk analysis

See business risks, AI filing insights, and deeper research for this stock. Create a free account to continue — includes a 14-day Pro trial.

No card required • Free plan stays after trial

About this summary

Summary generated on Apr 25, 2026.

Latest Report Overview for Molina Healthcare Inc ($MOH)

AI-powered analysis of Molina Healthcare Inc (MOH) stock based on Q1 2026 financial data.

Published: April 25, 2026

Latest Report Overview

Key Takeaways for Molina Healthcare Inc

Revenue growth decelerated to -3.1% YoY in Q1 2026, marking a significant inflection point from the 8.3% growth seen in Q4 2025.
Medical care costs continue to press on profitability, with Q1 2026 operating margins thinning to 0.8%, highlighting the volatility in managing government-sponsored plan costs.
The company maintains a strong liquidity position with $5.314 billion in cash as of Q1 2026, providing flexibility for strategic M&A and capital management despite margin pressures.
Strategic shift away from Medicare Advantage (MAPD) continues as the company focuses on its dual-eligible core competencies, exiting markets to improve long-term profitability.
Active management of the capital structure remains a priority, evidenced by the refinancing of debt and ongoing opportunistic share repurchases as authorized by the board.

What Does Molina Healthcare Inc Do?

Growth Drivers for Molina Healthcare Inc

Winning new Medicaid and Medicare state procurement contracts (e.g., recent wins in Idaho, Michigan, Massachusetts, Ohio, Wisconsin, Nevada, Illinois, Florida).